These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8100928

  • 1. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
    Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, Geddes D, Hodson M.
    Lancet; 1993 Jul 24; 342(8865):199-202. PubMed ID: 8100928
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE.
    Eur Respir J; 1995 Jun 24; 8(6):954-8. PubMed ID: 7589382
    [Abstract] [Full Text] [Related]

  • 3. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL, Scott SF, Fuchs HJ, Geddes DM, Hodson ME.
    Thorax; 1995 Apr 24; 50(4):333-8. PubMed ID: 7785003
    [Abstract] [Full Text] [Related]

  • 4. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV.
    Am Rev Respir Dis; 1993 Jul 08; 148(1):145-51. PubMed ID: 8317790
    [Abstract] [Full Text] [Related]

  • 6. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME.
    Thorax; 1996 Feb 08; 51(2):119-25. PubMed ID: 8711640
    [Abstract] [Full Text] [Related]

  • 7. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul 08; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
    McCoy K, Hamilton S, Johnson C.
    Chest; 1996 Oct 08; 110(4):889-95. PubMed ID: 8874241
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME.
    Am J Respir Crit Care Med; 1995 Mar 08; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
    van der Giessen LJ, Gosselink R, Hop WC, Tiddens HA.
    Eur Respir J; 2007 Oct 08; 30(4):763-8. PubMed ID: 17596273
    [Abstract] [Full Text] [Related]

  • 17. Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview.
    Hodson ME.
    Respiration; 1995 Oct 08; 62 Suppl 1():29-32. PubMed ID: 7792438
    [Abstract] [Full Text] [Related]

  • 18. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R, Metcalfe C, Wallis C, Bush A.
    Pediatr Pulmonol; 2004 Apr 08; 37(4):305-10. PubMed ID: 15022126
    [Abstract] [Full Text] [Related]

  • 19. [Clinical development of rhDNase in the United States].
    Eisenberg J.
    Arch Pediatr; 1995 Jul 08; 2(7):674-8. PubMed ID: 7663659
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.